Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2014
08/27/2014EP2769734A1 A vaccine directed against porcine pleuropneumonia and a method to obtain such a vaccine
08/27/2014EP2769733A1 Stabilised mRNA encoding MUC1 against cancer
08/27/2014EP2769731A1 Methods to activate or block the HLA-E/QA-1 restricted CD8+ T cell regulatory pathway to treat immunological disease
08/27/2014EP2769711A1 Methods and Compositions for Enhanced Delivery of Macromolecules
08/27/2014EP2768964A1 Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
08/27/2014EP2768860A1 Antibodies directed against the alpha chain of il7 receptor - their use for the preparation of drug candidates
08/27/2014EP2768855A2 Stable multiple antigen-binding antibody
08/27/2014EP2768847A1 Dengue virus e-glycoprotein polypeptides containing mutations that eliminate immunodominant cross-reactive epitopes
08/27/2014EP2768535A1 Etanercept formulations stabilized with xylitol
08/27/2014EP2768534A1 Antigen presenting cancer vaccine
08/27/2014EP2768533A1 Etanercept formulations stabilized with combinations of sugars and polyols
08/27/2014EP2768532A1 Etanercept formulations stabilized with sodium chloride
08/27/2014EP2768531A1 Etanercept formulations stabilized with meglumine
08/27/2014EP2768530A1 Recombinant self-replicating polycistronic rna molecules
08/27/2014EP2768529A1 Recombinant nonpathogenic mdv vector providing multivalent immunity
08/27/2014EP2768528A1 Adjuvanted influenza b virus vaccines for pediatric priming
08/27/2014EP2768527A1 Multi-cbv vaccine for preventing or treating type 1 diabetes
08/27/2014EP2768526A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
08/27/2014EP2768525A1 Etanercept formulations stabilized with metal ions
08/27/2014EP2768524A1 Pd-l1 based immunotherapy
08/26/2014US8816055 Plasma kallikrein binding proteins
08/26/2014US8816053 Methods for treating viral infection using IL-28 and IL-29 cysteine mutants
08/26/2014US8815823 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/26/2014US8815808 Modulation of activity of neurotrophins
08/26/2014US8815564 Replication-defective flavivirus vaccines and vaccine vectors
08/26/2014US8815503 Compositions and methods for immunostimulatory RNA oligonucleotides
08/26/2014US8815501 Flavivirus NS1 subunit vaccine
08/26/2014US8815277 In situ forming hydrogel and biomedical use thereof
08/26/2014US8815256 Induction of tumor immunity by variants of folate binding protein
08/26/2014US8815255 Use of Mycoplasma bovis antigen
08/26/2014US8815254 Method of detoxification
08/26/2014US8815253 Compositions for inducing immune responses
08/26/2014US8815252 Method for production of pH stable enveloped viruses
08/26/2014US8815251 Microbial delivery system
08/26/2014US8815250 Clotting factor-Fc chimeric proteins to treat hemophilia
08/26/2014US8815249 Ii-key/antigenic epitope hybrid peptide vaccines
08/26/2014US8815248 Modulation of immunity and CEACAM1 activity
08/26/2014US8815247 Targeted/immunomodulatory fusion proteins
08/26/2014US8815245 Method of treating viral diseases
08/26/2014US8815244 Method for production of antibody using ostrich
08/26/2014US8815243 Pharmaceutical composition with antibody that binds to heat shock protein 27(HSP270) and method for promoting wound healing
08/26/2014US8815242 Avian derived antibodies
08/26/2014US8815241 Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
08/26/2014US8815240 Methods and agents for the diagnosis and treatment of hepatocellular carcinoma
08/26/2014US8815239 Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X
08/26/2014US8815238 Methods for Preparing TACI-immunoglobulin fusion proteins
08/26/2014US8815237 Aglycosylated immunoglobulin mutants
08/26/2014US8815236 Method for treating multiple sclerosis and crohn's disease
08/26/2014US8815235 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface
08/26/2014US8815211 Radioactive metal-labeled anti-cadherin antibody
08/26/2014CA2761105C Phage lambda display constructs
08/26/2014CA2614080C Anti-ccr7 receptor antibodies for the treatment of cancer
08/26/2014CA2582252C Therapeutic use of anti-tf-antigen antibody
08/26/2014CA2530797C Vaccine composition for vaccinating dogs against canine infectious respiratory disease (cird)
08/26/2014CA2476755C Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
08/26/2014CA2467309C Type iii secretion pathway in aeromonas salmonicida, and uses therefor
08/26/2014CA2390344C 85kda neisserial antigen
08/26/2014CA2373236C Combination neisserial compositions
08/21/2014WO2014127357A1 Supramolecular magnetic nanoparticles
08/21/2014WO2014127351A2 Compositions and methods to alter gut microbial fermentation using sulfate-reducing bacteria
08/21/2014WO2014127296A1 Cancer vaccines and vaccination methods
08/21/2014WO2014127276A1 Ovarian cancer vaccines and vaccination methods
08/21/2014WO2014127231A1 Oligomeric influenza immunogenic compositions
08/21/2014WO2014127220A1 Antigen-specific t cell redirectors
08/21/2014WO2014127200A1 Chimeric and humanized anti-histone antibodies
08/21/2014WO2014127185A1 Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
08/21/2014WO2014127155A2 Methods of identifying, preventing, and treating virulent hand foot and mouth disease virus using replikin sequences
08/21/2014WO2014127006A1 Composition and method for diagnosis and immunotherapy of lung cancer
08/21/2014WO2014126921A1 Monoclonal antibodies that neutralize norovirus
08/21/2014WO2014126796A2 Methods of diagnosing, treating and monitoring diabetic retinopathy
08/21/2014WO2014126510A2 Polyvalent fusion protein vaccine against influenza
08/21/2014WO2014125053A1 Methods for the release of virus-like particles
08/21/2014WO2014125041A1 Treatment of peripheral t cell lymphoma
08/21/2014WO2014124523A1 A method of treating obesity
08/21/2014WO2014089209A3 Blood-brain barrier (bbb) penetrating dual specific binding proteins
08/21/2014WO2014085821A3 Fully human antibodies and fragments recognizing human c-met
08/21/2014WO2014083567A8 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
08/21/2014US20140237631 Neurovirulent Strain of the West Nile Virus and Uses Thereof
08/21/2014US20140235835 Calicheamicin derivative-carrier conjugates
08/21/2014US20140235832 Rank ligand polypeptides
08/21/2014US20140234859 Controlled platelet activation to monitor therapy of adp antagonists
08/21/2014US20140234424 Prame purification
08/21/2014US20140234423 Programming of cells for tolerogenic therapies
08/21/2014US20140234422 Vaccine Composition With Aluminium Hydroxide Nanoparticles
08/21/2014US20140234410 Combination products
08/21/2014US20140234404 Liposome compositions comprising an adjuvant that activates or increases the activity of TLR2 and uses thereof
08/21/2014US20140234400 Targeted Lipid-Drug Formulations for Delivery of Drugs to Myeloid and Lymphoid Immune Cells
08/21/2014US20140234399 Hiv vaccine
08/21/2014US20140234377 Vaccine composition for mucosal administration
08/21/2014US20140234375 Compositions and Methods for Eliciting an Immune Response to Escape Mutants of Targeted Therapies
08/21/2014US20140234374 Compositions and methods for activating innate and allergic immunity
08/21/2014US20140234373 Methods of Promoting Immune Tolerance
08/21/2014US20140234372 Novel vlps derived from cells that do not express a viral matrix or core protein
08/21/2014US20140234370 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
08/21/2014US20140234369 Live-attenuated compositions for bacterial infections
08/21/2014US20140234368 Hypo- and hyper-acetylated meningococcal capsular saccharides
08/21/2014US20140234364 Total synthesis and immunological evaluation of saccharide moieties of the lipopolysaccharide from neisseria meningitidis
08/21/2014US20140234363 Polypeptides from non-typeable haemophilus influenzae
08/21/2014US20140234359 Plant viral vaccines and therapeutics
08/21/2014US20140234358 Newcastle disease virus vectored avian vaccines
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 1823